dsm-firmenich repurchases 313,835 shares for €30.3 million in latest buyback week

dsm-firmenich··CHNL·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

dsm-firmenich repurchased 313,835 of its own shares during the week of September 21 to September 25, 2026, at an average price of €96.45 per share for a total of €30.3 million. The purchases are part of a €540 million repurchase program the company began on March 12, 2026, which splits into €40 million to cover commitments under the Group's share-based compensation plans and €500 million to reduce its issued capital. The €40 million share-plan tranche was finalized on March 23, 2026, while the €500 million capital-reduction tranche is intended to be completed by the end of Q3 2026. To date, 6,976,047 shares have been repurchased under the program at an average price of €74.68, for a total consideration of €520.9 million. The program follows dsm-firmenich's February 9, 2026 announcement of its intention to buy back ordinary shares with an aggregate market value of €500 million and reduce its issued capital.

Impact on assets 2

Synthetic Biology (non-pharma)▲
DSM-Firmenich AG
DSFIR
▲ PositiveCapitalrelevance

dsm-firmenich repurchased 313,835 own shares for €30.3 million under its €540 million buyback program, reducing issued capital.

Critical Materials & Supply Chain▲